Google is working on ‘bioelectronics’ with a British pharmaceutical giant

‘Google’s parent company Alphabet is setting up a new “bioelectonics” venture with FTSE 100 pharmaceutical giant GlaxoSmithKline (GSK).
GSK will own 55% of the new joint venture, called Galvani Bioelectronics, while Alphabet’s Verily Life Sciences (formerly Google Life Sciences) will own the rest.
The two companies will invest £540 million in the new UK-based business over 7 years, as well as contributing intellectual property rights to Galvani. Galvani will “enable the research, development, and commercialisation of bioelectronic medicines.”‘
Read more: Google is working on ‘bioelectronics’ with a British pharmaceutical giant